Publishing research using ab108389? Please let us know so that we can cite the reference in this datasheet.
ab108389 has been referenced in 7 publications.
- Chen K et al. Both serum and tissue Galectin-1 levels are associated with adverse clinical features in neuroblastoma. Pediatr Blood Cancer 65:e27229 (2018). PubMed: 29797641
- Gao Y et al. Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer. Cell Death Dis 9:416 (2018). PubMed: 29549328
- You Y et al. MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma. Oncotarget 7:57099-57116 (2016). PubMed: 27494859
- Pereira PM et al. Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy. PLoS One 9:e95529 (2014). WB, ICC/IF ; Human . PubMed: 24763311
- Gurel Z et al. Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy. PLoS One 9:e95561 (2014). WB ; Mouse . PubMed: 24788674
- Lee YJ et al. Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis. Korean Circ J 43:223-30 (2013). WB, IHC-FoFr ; Mouse . PubMed: 23682281
- Miwa HE et al. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. Glycobiology 23:1477-90 (2013). Mouse . PubMed: 24037315